Huang An-Cheng, Hsu Shu-Chun, Kuo Chao-Lin, Liao Ching-Lung, Lai Kuang-Chi, Lin Tsung-Ping, Wu Shin-Hwar, Lu Hsu-Feng, Tang Nou-Ying, Yang Jai-Sing, Chung Jing-Gung
Department of Nursing, St. Mary's Medicine Nursing and Management College, Sansing Township, Yilan County 266, Taiwan, R.O.C.
In Vivo. 2009 Jul-Aug;23(4):613-9.
JOTO1007 (ethyl 2-[N-p-chlorobenzyl-(2'-methyl)] anilino-4-oxo-4,5-dihydrofuran -3-carboxylate) has anticancer effects in human cervical cancer Ca Ski cells. However, its mechanism of action on the cell migration and invasion of human cervical cancer Ca Ski cells is not fully understood. In this study, firstly, the effects of JOTO1007 on the migration and invasion of Ca Ski cells were examined by using matrigel counting. The results showed that JOTO1007 suppressed the migration and invasion of the Ca Ski cells. Secondly, the effect of JOTO1007 on the levels of proteins associated with cell metastasis was examined using Western blotting. The results indicated that JOTO1007 inhibited the levels of son of sevenless homolog 1 (SOS-1), growth factor receptor-bound protein 2 (GRB2), Ras homolog gene family, member A (RhoA), Rho-associated, coiled-coil containing protein kinase 1 (ROCK-1), focal adhesion kinase (FAK), phosphorylated-c-jun (p-c-jun), nuclear factor kappa B (NF-kappaB) p65, cyclooxygenase-2 (COX-2), extracellular signal-regulated kinases 1/2 (ERK1/2), matrix metalloproteinase-2 (MMP-2), MMP-7 and MMP-9 but promoted the levels of protein kinase C (PKC), phosphoinositide 3-kinases (PI3K), MAP kinase kinase kinase 3 (MEKK3), mitogen-activated protein kinase kinase 7 (MKK7), c-jun and inducible nitric oxide synthases (iNOS), while not affecting Ras, phosphorylated-ERK (p-ERK), p38 and c-jun N-terminal kinase 1/2 (JNK1/2), which finally led to the inhibition of migration and invasion of the Ca Ski cells in vitro. Overall, JOTO1007 inhibited NF-kappaB which then led to the inhibition of the MMP-2, -7 and -9 expression followed by the inhibition of migration and invasion in the Ca Ski cells.
JOTO1007(2-[N-对氯苄基-(2'-甲基)]苯胺基-4-氧代-4,5-二氢呋喃-3-羧酸乙酯)对人宫颈癌Ca Ski细胞具有抗癌作用。然而,其对人宫颈癌Ca Ski细胞迁移和侵袭的作用机制尚未完全明确。在本研究中,首先,通过基质胶计数检测JOTO1007对Ca Ski细胞迁移和侵袭的影响。结果显示,JOTO1007抑制了Ca Ski细胞的迁移和侵袭。其次,使用蛋白质印迹法检测JOTO1007对与细胞转移相关蛋白水平的影响。结果表明,JOTO1007抑制了七号无翅型同源物1(SOS-1)、生长因子受体结合蛋白2(GRB2)、Ras同源基因家族成员A(RhoA)、Rho相关卷曲螺旋蛋白激酶1(ROCK-1)、粘着斑激酶(FAK)、磷酸化c-jun(p-c-jun)、核因子κB(NF-κB)p65、环氧化酶-2(COX-2)、细胞外信号调节激酶1/2(ERK1/2)、基质金属蛋白酶-2(MMP-2)、MMP-7和MMP-9的水平,但促进了蛋白激酶C(PKC)、磷脂酰肌醇3-激酶(PI3K)、丝裂原活化蛋白激酶激酶激酶3(MEKK3)、丝裂原活化蛋白激酶激酶7(MKK7)、c-jun和诱导型一氧化氮合酶(iNOS)的水平,而对Ras、磷酸化ERK(p-ERK)、p38和c-jun氨基末端激酶1/2(JNK1/2)无影响,这最终导致体外Ca Ski细胞迁移和侵袭受到抑制。总体而言,JOTO1007抑制NF-κB,进而导致MMP-2、-7和-9表达受到抑制,随后Ca Ski细胞的迁移和侵袭也受到抑制。